Test-retest reliability of drug-induced sleep endoscopy using midazolam

J Clin Sleep Med. 2020 May 15;16(5):675-678. doi: 10.5664/jcsm.8314. Epub 2020 Feb 6.

Abstract

Study objectives: Drug-induced sleep endoscopy (DISE) has been suggested to be a valuable method for determining the obstruction patterns causing sleep-disordered breathing. However, since DISE is not performed throughout the duration of sleep but for less than 1 hour, the reproducibility and reliability of DISE are questionable. Therefore, we aimed to determine the test-retest reliability of DISE using midazolam.

Methods: Thirty-four patients diagnosed with obstructive sleep apnea were prospectively included in this study. The patients underwent 2 separate DISE examinations that were performed at different days using the same drug and technique. For a more accurate comparison, the depth of sleep and examination time were identically controlled. VOTE classification was used to classify the obstruction findings, and the findings of upper airway obstruction were compared between the 2 tests.

Results: There were 30 men and four women; the mean age was 45.4 ± 13.1 years. The mean apnea-hypopnea index was 38.3 ± 22.6, and the lowest oxygen saturation was 77.5% ± 12.4%. The lateral wall of the oropharynx, tongue base, and epiglottis showed very good agreement, and the velum showed good agreement between the first and second DISE examinations.

Conclusions: The reliability of DISE is debatable because it observes only a small portion of the total sleep, but this study suggests that DISE is a reliable test because the findings of 2 separate DISE examinations on different days showed a high concordance rate.

Keywords: endoscopy; midazolam; obstructive sleep apnea; reproducibility of results.

MeSH terms

  • Adult
  • Endoscopy
  • Female
  • Humans
  • Male
  • Midazolam*
  • Middle Aged
  • Pharmaceutical Preparations*
  • Polysomnography
  • Reproducibility of Results
  • Sleep

Substances

  • Pharmaceutical Preparations
  • Midazolam